1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 13 JULY 2015

Cancer Drug News 13 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Atezolizumab Will Be Significant Anti-PD-1 Competitor In 2016
Industry Brief - EU Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Brief - Daratumumab EAP Open To Eligible MM Patients In US
Industry Brief - Imbruvica Gains EU Approval For WM
Industry Brief - Mylan Launches Bexarotene In US
Industry Brief - Dosing Begins In Epizyme's Tazemetostat Five-Arm Phase II Study In r/r NHL
Industry Trend Analysis - Necitumumab Closes In On Approval
Industry Brief - Custirsen Phase III NSCLC Trial Continues Following IDMC Recommendation
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Trend Analysis - Oncolytics Biotech Will Be Target For Immunotherapy Partnerships
Industry Brief - Blaze's BLZ-100 Gains FDA ODD For Brain Cancer
Industry Brief - FDA Grants Fast Track Designation To Tocagen's Toca 511 And Toca FC
Industry Brief - AstraZeneca/Innate Co-Development Deal For IPH2201 Receives HSR Clearance
Industry Brief - Globavir Exclusively Licenses Oncology Compound To Sorrento

Table Of Contents

Cancer Drug News 13 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.